For pharmaceutical developers and manufacturers, securing high-quality intermediates is paramount to successful API production. One such critical compound is Tert-Butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate, identified by its CAS number 83056-79-5. This molecule is a key building block in the synthesis of Imidapril, a widely used pharmaceutical agent. Understanding its properties and how to source it effectively from reputable manufacturers is vital for ensuring production efficiency and product integrity.

Tert-Butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate is characterized by its white powder appearance and a high purity level, typically exceeding 98.0%. These specifications are crucial for downstream chemical reactions, particularly in the precise synthesis pathways required for active pharmaceutical ingredients (APIs). As a chemical intermediate, its role in forming the final Imidapril structure is indispensable. Therefore, buyers often look for suppliers who can guarantee consistent quality and reliable performance.

When considering where to buy this essential chemical, it's beneficial to explore suppliers based in China, a global hub for chemical manufacturing. Many Chinese manufacturers specialize in producing pharmaceutical intermediates like CAS 83056-79-5, offering competitive pricing and the capacity for both small-scale R&D needs and large-scale commercial orders. Prospective buyers should look for manufacturers who provide detailed product specifications, Certificates of Analysis (CoA), and Material Safety Data Sheets (MSDS).

The process of purchasing this intermediate typically involves requesting a quote, discussing packaging requirements (such as 25kg drums), and understanding lead times for delivery. Establishing a relationship with a trusted supplier means more than just obtaining a product; it involves ensuring a stable supply chain, which is critical for maintaining production schedules. For those actively seeking to purchase Tert-Butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate, partnering with experienced chemical manufacturers in China can significantly streamline procurement and enhance the overall efficiency of your Imidapril production process. This approach ensures you get the necessary pharmaceutical intermediate at a competitive price, directly from the source.